This formulary lists the medicines and related pharmaceutical products that are approved for use in the County Durham and Darlington NHS area. Please note that combination preparations are considered non-formulary unless they are specifically included within the formulary.
A formulary is only as good as the guidelines which underpin it. It is essential that this formulary is used in conjunction with the current guidelines. Throughout this formulary links to NICE and local guidelines are provided. This guidance should be read before selecting a drug from this formulary.
It is recognised that we cannot expect 100% compliance. This formulary will only cover 80-90% of what may be needed for individual patients.
The County Durham and Darlington DO NOT PRESCRIBE List can be accessed online at: http://medicines.necsu.nhs.uk/guidelines/durham-darlington
The County Durham and Darlington APC Grey List – items to be prescribed in certain specific circumstances only can be accessed online at:http://medicines.necsu.nhs.uk/guidelines/durham-darlington
The APPLICATION FOR NEW PRODUCT TO BE APPROVED FOR USE IN NHS COUNTY DURHAM AND DARLINGTON be accessed online at:http://medicines.necsu.nhs.uk/wp-content/uploads/2013/12/APC-New-Product-Application-Form.pdf
The Feedback / Notification of off-formulary / off-guideline prescribing Form can be accessed online at:http://medicines.necsu.nhs.uk/committees/durham-darlington-committees
The County Durham and Darlington Formulary Guide to RAG list classifications can be accessed online at:http://medicines.necsu.nhs.uk/committees/durham-darlington-committee
The County Durham and Darlington Formulary Process can be accessed online at: http://medicines.necsu.nhs.uk/committees/durham-darlington-committees
Minutes of meetings, Terms of Reference, and all other documentation relating to the County Durham and Darlington Area Prescribing Committee can be accessed online at: http://medicines.necsu.nhs.uk/committees/durham-darlington-committees
Definition of RAG Categories within the formulary:
Annotations used within the formulary:
▼ Medicines that are being monitored particularly closely by regulatory authorities in the European Union (EU) are described as being under 'additional monitoring'. Medicines under additional monitoring will have an inverted Black Triangle displayed. Healthcare professionals are asked to report any suspected adverse reactions.
u or unlicensed = indications which medicines or indications included with the formulary currently do not have UK product license